ProvideGx, a subsidiary of Premier, will collaborate with Fresenius Kabi to help mitigate national shortages of five generic injectable medications.
Pharmacy
Civica Rx, the nonprofit generic drugmaker formed by a group of health systems, will begin by distributing two essential antibiotics, the company announced May 15.
Johnson & Johnson and Teva Pharmaceuticals lost a last-minute bid to escape an opioid lawsuit brought against them by the state of Oklahoma, according to Reuters.
Kentucky is suing three insulin makers — Eli Lilly, Sanofi and Novo Nordisk — over alleged price-gouging, according to The Hill. The state is the latest to sue insulin manufacturers over the pricing of the product.
AbbVie and Boehringer Ingelheim have resolved their patent dispute over a biosimilar to Humira, the companies announced May 14.
Advertisement
Medications purchased at discounted rates under the federal 340B program hit a record $24.3 billion in 2018, up 26 percent from 2017, according to Health Resources and Service Administration data cited by pharmaceutical website Drug Channels.
A San Francisco jury ordered Bayer to pay more than $2 billion to a couple who claimed the company's weedkiller caused their cancer, according to CNBC.
The $300 billion of Chinese imports potentially subject to U.S. tariffs won't include pharmaceuticals and select medical products, according to Reuters.
An assistant pharmacy professor at the University of Rhode Island in South Kingstown resigned after she was convicted of defrauding government regulators by dispensing drugs without valid prescriptions, according to The Providence Journal.
Purdue Pharma has removed the signs bearing its name and logo at its downtown headquarters in Stamford, Conn., according to the Stamford Advocate.